Readout Capital, LP - 30 Jun 2025 SCHEDULE 13G/A Report for PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share (DTIL)

Filing Manager
Readout Capital, LP
Reporting Manager
Matthew Smith
Security
PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share
Symbol
DTIL
Shares outstanding
11,907,564 shares
Disclosed Ownership
1,119,311 shares
Ownership
9.4%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:09:34 UTC
Date of event
30 Jun 2025
Previous filing
26 Mar 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Readout Capital, LP disclosed 9.4% ownership in PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share (DTIL) on 30 Jun 2025."

Quick Takeaways

  • Readout Capital, LP filed SCHEDULE 13G/A for PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share (DTIL).
  • Disclosed ownership: 9.4%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 26 Mar 2025.
  • Current filing was accepted on 14 Aug 2025, 16:09.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Readout Capital, LP 9.3% 1,106,437 200,000 906,437 /s/ Matthew Smith Matthew Smith/Manager, Readout Capital GP, LLC, its General Partner
Readout Capital GP, LLC 9.3% 1,106,437 200,000 906,437 /s/ Matthew Smith Matthew Smith/Manager
ROC Holdings SPV II, LP 7.6% 906,437 0 906,437 /s/ Matthew Smith Matthew Smith/Manager, Readout Holdings GP, LLC, its General Partner
Readout Holdings GP, LLC 7.6% 906,437 0 906,437 /s/ Matthew Smith Matthew Smith/Manager
Matthew Smith 9.4% 1,119,311 212,874 906,437 /s/ Matthew Smith Matthew Smith/Self

Sponsored